Inhibition of the mitochondrial fission dynamin-related protein-1 attenuates insulin resistance in hepatoma cells: Implication of mitochondrial dysfunction, apoptosis and nucleolar disruption

Original scientific paper

Authors

  • Mai H. Hassan MCB Unit, Division of Biochemistry, Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt https://orcid.org/0000-0002-3488-7741
  • Thoria Donia MCB Unit, Division of Biochemistry, Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt https://orcid.org/0000-0002-1629-1290
  • Mohamed Hessien MCB Unit, Division of Biochemistry, Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt https://orcid.org/0000-0002-3782-1633

DOI:

https://doi.org/10.5599/admet.3512

Keywords:

Hyperglycaemia, mitochondrial dynamics, Mdivi-1, diabetes mellites, ribosomal biogenesis

Abstract

Background and purpose: Chronic hyperglycaemia, a defining feature of diabetes mellitus, is closely associated with excessive mitochondrial fragmentation. Accordingly, inhibition of mitochondrial fission has been proposed as a potential strategy for alleviating insulin resistance; however, the associated mitochondrial, cellular, and nuclear consequences remain insufficiently characterised. Experimental approach: In the present study, an insulin-resistant (IR) cellular model was established in HepG2 cells and treated with the mitochondrial division inhibitor (Mdivi-1), a selective inhibitor of dynamin-related protein-1 (DRP1). Key results: Exposure of cells to high-glucose medium (25 mM) and insulin (1 nM) decreased glucose uptake, enhanced reactive oxygen species (ROS) production, and downregulated insulin receptor substrate 1 (IRS-1). Also, Mdivi-1 treatment suppressed DRP1 expression in both Insulin-sensitive (IS) and insulin-resistant (IR) cells, upregulated mito­chondrial fusion-related genes (MFN1 and OPA1) in IR cells, and improved cellular glucose uptake. Notably, IR cells exhibited greater responsiveness to Mdivi-1 than IS cells, as evidenced by enhanced glucose utili­zation, elevated ROS generation, increased apoptosis (24.1 vs. 18.8 % in IS cells), and increased PI3K expres­sion. Despite improvements in insulin responsiveness, Mdivi-1 adversely impaired mitochondrial function, as demonstrated by reduced ATP production and decreased mitochondrial membrane potential (MMP). These alterations were accompanied by G0/G1 cell-cycle arrest, chromatin condensation, downregulation of mTORC1, and impaired ribosomal biogenesis, with most cells exhibiting single hyper­trophic or fragmented nucleoli. Conclusion: These findings demonstrate that although Mdivi-1 ameliorated insulin resistance and partially restored insulin signalling, its beneficial effects are accompanied by mitochondrial dysfunction, enhanced apoptosis, and nucleolar alterations. These observations underscore the necessity for therapeutic strategies that selectively restrict mitochondrial fission while preserving mitochondrial integrity and cellular viability.

Downloads

Download data is not yet available.

References

[1] S.B. Yu, G. Pekkurnaz. Mechanisms Orchestrating Mitochondrial Dynamics for Energy Homeostasis. J. Mol. Biol. 430 (2018) 3922-3941. https://doi.org/10.1016/j.jmb.2018.07.027 DOI: https://doi.org/10.1016/j.jmb.2018.07.027

[2] S.B. Berman, F.J. Pineda, J.M. Hardwick. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ. 15 (2008) 1147-1152. https://doi.org/10.1038/cdd.2008.57 DOI: https://doi.org/10.1038/cdd.2008.57

[3] A.M. Joseph, D.R. Joanisse, R.G. Baillot, D.A. Hood. Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions. Exp. Diabetes Res. 2012 (2012) 642038. https://doi.org/10.1155/2012/642038 DOI: https://doi.org/10.1155/2012/642038

[4] B.B. Lowell, G.I. Shulman. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387. https://doi.org/10.1126/science.1104343 DOI: https://doi.org/10.1126/science.1104343

[5] S. Rovira-Llopis, C. Bañuls, N. Diaz-Morales, A. Hernandez-Mijares, M. Rocha, V.M. Victor. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications. Redox Biol. 11 (2017) 637-645. https://doi.org/10.1016/j.redox.2017.01.013 DOI: https://doi.org/10.1016/j.redox.2017.01.013

[6] G. Twig, A. Elorza, A.J. Molina, H. Mohamed, J.D. Wikstrom, G. Walzer, L. Stiles, S.E. Haigh, S. Katz, G. Las, J. Alroy, M. Wu, B.F. Py, J. Yuan, J.T. Deeney, B.E. Corkey, O.S. Shirihai. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27 (2008) 433-446. https://doi.org/10.1038/sj.emboj.7601963 DOI: https://doi.org/10.1038/sj.emboj.7601963

[7] W. Wang, Y. Wang, J. Long, J. Wang, S.B. Haudek, P. Overbeek, B.H. Chang, P.T. Schumacker, F.R. Danesh. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15 (2012) 186-200. https://doi.org/10.1016/j.cmet.2012.01.009 DOI: https://doi.org/10.1016/j.cmet.2012.01.009

[8] S. Kumari, L. Anderson, S. Farmer, S.L. Mehta, P.A. Li. Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion. Transl. Stroke Res. 3 (2012) 296-304. https://doi.org/10.1007/s12975-012-0158-9 DOI: https://doi.org/10.1007/s12975-012-0158-9

[9] K.F. Petersen, D. Befroy, S. Dufour, J. Dziura, C. Ariyan, D.L. Rothman, L. DiPietro, G.W. Cline, G.I. Shulman. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142. https://doi.org/10.1126/science.1082889 DOI: https://doi.org/10.1126/science.1082889

[10] T. Vezza, P. Díaz-Pozo, F. Canet, A.M. de Marañón, Z. Abad-Jiménez, C. García-Gargallo, I. Roldan, E. Solá, C. Bañuls, S. López-Domènech, M. Rocha, V.M. Víctor. The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes. World J. Mens Health 40 (2022) 399-411. https://doi.org/10.5534/wjmh.210146 DOI: https://doi.org/10.5534/wjmh.210146

[11] Q.R. Wu, D.L. Zheng, P.M. Liu, H. Yang, L.A. Li, S.J. Kuang, Y.Y. Lai, F. Rao, Y.M. Xue, J.J. Lin, S.X. Liu, C.B. Chen, C.Y. Deng. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy. Cell Death Dis. 12 (2021) 216. https://doi.org/10.1038/s41419-021-03502-4 DOI: https://doi.org/10.1038/s41419-021-03502-4

[12] W. Dai, L. Jiang. Dysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer. Front. Endocrinol. 10 (2019) 570. https://doi.org/10.3389/fendo.2019.00570 DOI: https://doi.org/10.3389/fendo.2019.00570

[13] S.M. Shenouda, M.E. Widlansky, K. Chen, G. Xu, M. Holbrook, C.E. Tabit, N.M. Hamburg, A.A. Frame, T.L. Caiano, M.A. Kluge, M.A. Duess, A. Levit, B. Kim, M.L. Hartman, L. Joseph, O.S. Shirihai, J.A. Vita. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124 (2011) 444-453. https://doi.org/10.1161/circulationaha.110.014506 DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.014506

[14] T. Yu, I. Wang, L. Zhang, P.A. Deuster. Mitochondrial Fission as a Therapeutic Target for Metabolic Diseases: Insights into Antioxidant Strategies. Antioxidants 12 (2023) 1163. https://doi.org/10.3390/antiox12061163 DOI: https://doi.org/10.3390/antiox12061163

[15] S.D. Fakhir, I.S. Arif, H.J. Waheed. Dual GLP-1/GIP agonist tirzepatide modulates hepatic mitochondrial fusion–fission gene expression and oxidative stress in diabetic rats. Pharmacia 72 (2025) 1-16. https://doi.org/10.3897/pharmacia.72.e175259 DOI: https://doi.org/10.3897/pharmacia.72.e175259

[16] M.M. Mariappan, K. D'Silva, M.J. Lee, K. Sataranatarajan, J.L. Barnes, G.G. Choudhury, B.S. Kasinath. Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. Am. J. Physiol. Renal Physiol. 300 (2011) F219-F230. https://doi.org/10.1152/ajprenal.00207.2010 DOI: https://doi.org/10.1152/ajprenal.00207.2010

[17] L. Jiao, Y. Liu, X.Y. Yu, X. Pan, Y. Zhang, J. Tu, Y.H. Song, Y. Li. Ribosome biogenesis in disease: new players and therapeutic targets. Signal Transduct. Target. Ther. 8 (2023) 15. https://doi.org/10.1038/s41392-022-01285-4 DOI: https://doi.org/10.1038/s41392-022-01285-4

[18] Cassidy-Stone, J.E. Chipuk, E. Ingerman, C. Song, C. Yoo, T. Kuwana, M.J. Kurth, J.T. Shaw, J.E. Hinshaw, D.R. Green, J. Nunnari. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 14 (2008) 193-204. https://doi.org/10.1016/j.devcel.2007.11.019 DOI: https://doi.org/10.1016/j.devcel.2007.11.019

[19] E.A. Bordt, P. Clerc, B.A. Roelofs, A.J. Saladino, L. Tretter, V. Adam-Vizi, E. Cherok, A. Khalil, N. Yadava, S.X. Ge, T.C. Francis, N.W. Kennedy, L.K. Picton, T. Kumar, S. Uppuluri, A.M. Miller, K. Itoh, M. Karbowski, H. Sesaki, R.B. Hill, B.M. Polster. The Putative Drp1 Inhibitor Mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species. Dev. Cell 40 (2017) 583-594.e6. https://doi.org/10.1016/j.devcel.2017.02.020 DOI: https://doi.org/10.1016/j.devcel.2017.02.020

[20] A.I. Alalawy, M. Sakran, F.M. Alzuaibr, M.A. Alotaibi, M.E. El-Hefnawy, A.Y. Hazazi, S.M. El-Gendy, E.A. Aidy, H. Effat, D.F. Ismail, M. Hessien. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice. Sci. Rep. 13 (2023) 22782. https://doi.org/10.1038/s41598-023-49578-0 DOI: https://doi.org/10.1038/s41598-023-49578-0

[21] F. Gao, L. Jian, M.I. Zafar, W. Du, Q. Cai, R.A. Shafqat, F. Lu. 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins. Mol. Med. Rep. 12 (2015) 6555-6560. https://doi.org/10.3892/mmr.2015.4298 DOI: https://doi.org/10.3892/mmr.2015.4298

[22] F. Denizot, R. Lang. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277. https://doi.org/10.1016/0022-1759(86)90368-6 DOI: https://doi.org/10.1016/0022-1759(86)90368-6

[23] J.R. Cook, F. Langlet, Y. Kido, D. Accili. Pathogenesis of selective insulin resistance in isolated hepatocytes. J. Biol. Chem. 290 (2015) 13972-13980. https://doi.org/10.1074/jbc.M115.638197 DOI: https://doi.org/10.1074/jbc.M115.638197

[24] R.D. Yudhani, Y. Sari, D.A.A. Nugrahaningsih, E.N. Sholikhah, M. Rochmanti, A.K.R. Purba, H. Khotimah, D. Nugrahenny, M. Mustofa. In Vitro Insulin Resistance Model: A Recent Update. J. Obes. 2023 (2023) 1964732. https://doi.org/10.1155/2023/1964732 DOI: https://doi.org/10.1155/2023/1964732

[25] R.C. Su, A. Lad, J.D. Breidenbach, T.M. Blomquist, W.T. Gunning, P. Dube, A.L. Kleinhenz, D. Malhotra, S.T. Haller, D.J. Kennedy. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLoS ONE 14 (2019) e0225604. https://doi.org/10.1371/journal.pone.0225604 DOI: https://doi.org/10.1371/journal.pone.0225604

[26] V.A. Arzumanian, O.I. Kiseleva, E.V. Poverennaya. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int. J. Mol. Sci. 22 (2021) 13135. https://doi.org/10.3390/ijms222313135 DOI: https://doi.org/10.3390/ijms222313135

[27] D. Shunkina, A. Dakhnevich, E. Shunkin, O. Khaziakhmatova, V. Shupletsova, M. Vulf, A. Komar, E. Kirienkova, L. Litvinova. gp130 Activates Mitochondrial Dynamics for Hepatocyte Survival in a Model of Steatohepatitis. Biomedicines 11 (2023) 396. https://doi.org/10.3390/biomedicines11020396 DOI: https://doi.org/10.3390/biomedicines11020396

[28] D.E. James, J. Stöckli, M.J. Birnbaum. The aetiology and molecular landscape of insulin resistance. Nat. Rev. Mol. Cell Biol. 22 (2021) 751-771. https://doi.org/10.1038/s41580-021-00390-6 DOI: https://doi.org/10.1038/s41580-021-00390-6

[29] S.E. Kahn, R.L. Hull, K.M. Utzschneider. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846. https://doi.org/10.1038/nature05482 DOI: https://doi.org/10.1038/nature05482

[30] I.A. Alvarez, M. Lee, R.S. Eshaq, W. Leskova, N.R. Harris. High Glucose Induces Oxidative Stress That Alters Glycocalyx Proteoglycan Levels in Primary Rat Retinal Microvascular Endothelial Cells and in Isolated Ophthalmic Arteries. Pathophysiology 31 (2024) 89-99. https://doi.org/10.3390/pathophysiology31010007 DOI: https://doi.org/10.3390/pathophysiology31010007

[31] P. Kumar, G.N. Rao, B.B. Pal, A. Pal. Hyperglycemia-induced oxidative stress induces apoptosis by inhibiting PI3-kinase/Akt and ERK1/2 MAPK-mediated signaling pathway causing downregulation of 8-oxoG-DNA glycosylase levels in glial cells. Int. J. Biochem. Cell Biol. 53 (2014) 302-319. https://doi.org/10.1016/j.biocel.2014.05.038 DOI: https://doi.org/10.1016/j.biocel.2014.05.038

[32] M. Manczak, R. Kandimalla, X. Yin, P.H. Reddy. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum. Mol. Genet. 28 (2019) 177-199. https://doi.org/10.1093/hmg/ddy335 DOI: https://doi.org/10.1093/hmg/ddy335

[33] M.A. Rogers, J.D. Hutcheson, T. Okui, C. Goettsch, S.A. Singh, A. Halu, F. Schlotter, H. Higashi, L. Wang, M.C. Whelan, A.K. Mlynarchik, A. Daugherty, M. Nomura, M. Aikawa, E. Aikawa. Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion. Cardiovasc. Res. 117 (2021) 2340-2353. https://doi.org/10.1093/cvr/cvab034 DOI: https://doi.org/10.1093/cvr/cvab034

[34] M. Ma, X.H. Lin, H.H. Liu, R. Zhang, R.X. Chen. Suppression of DRP1-mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy. Oncol. Rep. 43 (2020) 1010-1018. https://doi.org/10.3892/or.2020.7476 DOI: https://doi.org/10.3892/or.2020.7476

[35] R.Z. Zhao, S. Jiang, L. Zhang, Z.B. Yu. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44 (2019) 3-15. https://doi.org/10.3892/ijmm.2019.4188 DOI: https://doi.org/10.3892/ijmm.2019.4188

[36] T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, M. Brownlee. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790. https://doi.org/10.1038/35008121 DOI: https://doi.org/10.1038/35008121

[37] N. Houstis, E.D. Rosen, E.S. Lander. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948. https://doi.org/10.1038/nature04634 DOI: https://doi.org/10.1038/nature04634

[38] Dumas, U.G. Knaus. Raising the 'Good' Oxidants for Immune Protection. Front. Immunol. 12 (2021) 698042. https://doi.org/10.3389/fimmu.2021.698042 DOI: https://doi.org/10.3389/fimmu.2021.698042

[39] M. Yamamoto, T.W. Kensler, H. Motohashi. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol. Rev. 98 (2018) 1169-1203. https://doi.org/10.1152/physrev.00023.2017 DOI: https://doi.org/10.1152/physrev.00023.2017

[40] H.J. Forman, M. Torres. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166 (2002) S4-S8. https://doi.org/10.1164/rccm.2206007 DOI: https://doi.org/10.1164/rccm.2206007

[41] S.I. Ahn, S.K. Choi, M.J. Kim, J. Wie, J.S. You. Mdivi-1: Effective but complex mitochondrial fission inhibitor. Biochem. Biophys. Res. Commun. 710 (2024) 149886. https://doi.org/10.1016/j.bbrc.2024.149886 DOI: https://doi.org/10.1016/j.bbrc.2024.149886

[42] E. Silva-Pavez, E. Mendoza, P. Morgado-Cáceres, U. Ahumada-Castro, G. Bustos, M. Kangme-Encalada, A.L. de Arbina, A. Puebla-Huerta, F. Muñoz, L. Cereceda, M. Varas-Godoy, Y. Hidalgo, J.C. Cardenas. Mitochondrial division inhibitor (Mdivi-1) induces extracellular matrix (ECM)-detachment of viable breast cancer cells by a DRP1-independent mechanism. Sci. Rep. 14 (2024) 14178. https://doi.org/10.1038/s41598-024-64228-9 DOI: https://doi.org/10.1038/s41598-024-64228-9

[43] O. Tusskorn, T. Khunluck, A. Prawan, L. Senggunprai, V. Kukongviriyapan. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells. Biomed. Pharmacother. 111 (2019) 109-118. https://doi.org/10.1016/j.biopha.2018.12.051 DOI: https://doi.org/10.1016/j.biopha.2018.12.051

[44] H.F. Jheng, P.J. Tsai, S.M. Guo, L.H. Kuo, C.S. Chang, I.J. Su, C.R. Chang, Y.S. Tsai. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell. Biol. 32 (2012) 309-319. https://doi.org/10.1128/mcb.05603-11 DOI: https://doi.org/10.1128/MCB.05603-11

[45] Gonzalez-Franquesa, M.E. Patti. Insulin Resistance and Mitochondrial Dysfunction. Adv. Exp. Med. Biol. 982 (2017) 465-520. https://doi.org/10.1007/978-3-319-55330-6_25 DOI: https://doi.org/10.1007/978-3-319-55330-6_25

[46] P. Langlais, Z. Yi, J. Finlayson, M. Luo, R. Mapes, E. De Filippis, C. Meyer, E. Plummer, P. Tongchinsub, M. Mattern, L.J. Mandarino. Global IRS-1 phosphorylation analysis in insulin resistance. Diabetologia 54 (2011) 2878-2889. https://doi.org/10.1007/s00125-011-2271-9 DOI: https://doi.org/10.1007/s00125-011-2271-9

[47] H.S. Ryu, S.Y. Park, D. Ma, J. Zhang, W. Lee. The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS ONE 6 (2011) e17343. https://doi.org/10.1371/journal.pone.0017343 DOI: https://doi.org/10.1371/journal.pone.0017343

[48] P. Sangwung, K.F. Petersen, G.I. Shulman, J.W. Knowles. Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications. Endocrinology 161 (2020) bqaa017. https://doi.org/10.1210/endocr/bqaa017 DOI: https://doi.org/10.1210/endocr/bqaa017

Downloads

Published

20-08-2026

Issue

Vol. 14 (2026)

Section

Medicinal chemistry

License

Copyright (c) 2026 Mai H. Hassan, Thoria Donia , Mohamed Hessien

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Inhibition of the mitochondrial fission dynamin-related protein-1 attenuates insulin resistance in hepatoma cells: Implication of mitochondrial dysfunction, apoptosis and nucleolar disruption: Original scientific paper. (2026). ADMET and DMPK, 14, Article 3512. https://doi.org/10.5599/admet.3512